Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Depreciation & Amortization (IS) (2016 - 2021)

Abeona Therapeutics has reported Depreciation & Amortization (IS) over the past 11 years, most recently at $807000.0 for Q4 2021.

  • Quarterly results put Depreciation & Amortization (IS) at $807000.0 for Q4 2021, down 3.93% from a year ago — trailing twelve months through Dec 2021 was $3.2 million (down 29.13% YoY), and the annual figure for FY2021 was $3.2 million, down 29.13%.
  • Depreciation & Amortization (IS) for Q4 2021 was $807000.0 at Abeona Therapeutics, up from $802000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for ABEO hit a ceiling of $2.1 million in Q1 2020 and a floor of $138000.0 in Q3 2017.
  • Median Depreciation & Amortization (IS) over the past 5 years was $817000.0 (2021), compared with a mean of $878105.3.
  • Biggest five-year swings in Depreciation & Amortization (IS): soared 852.87% in 2019 and later crashed 60.44% in 2021.
  • Abeona Therapeutics' Depreciation & Amortization (IS) stood at $146000.0 in 2017, then skyrocketed by 852.74% to $1.4 million in 2018, then surged by 46.08% to $2.0 million in 2019, then crashed by 58.66% to $840000.0 in 2020, then dropped by 3.93% to $807000.0 in 2021.
  • The last three reported values for Depreciation & Amortization (IS) were $807000.0 (Q4 2021), $802000.0 (Q3 2021), and $824000.0 (Q2 2021) per Business Quant data.